Amount of increase (decrease) in noncurrent assets classified as other.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-28

Name:	us-gaap_IncreaseDecreaseInOtherNoncurrentAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Litigation (Details) - USD ($) $ in Millions	3 Months Ended
Litigation (Details) - USD ($) $ in Millions	Dec. 31, 2022	Mar. 31, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Line Items]
Other assets		$ 191.4	$ 194.3
Jansen Pharmaceuticals, Inc.
Commitments and Contingencies Disclosure [Line Items]
Increase in other assets	$ 152.7
Other assets		$ 158.8